Surgery Partners Inc
NASDAQ:SGRY

Watchlist Manager
Surgery Partners Inc Logo
Surgery Partners Inc
NASDAQ:SGRY
Watchlist
Price: 23.32 USD -0.17%
Market Cap: 3B USD

Intrinsic Value

The intrinsic value of one SGRY stock under the Base Case scenario is 40.9 USD. Compared to the current market price of 23.32 USD, Surgery Partners Inc is Undervalued by 43%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

SGRY Intrinsic Value
40.9 USD
Undervaluation 43%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Surgery Partners Inc

Valuation History Unavailable

Historical valuation for SGRY cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%
Compare SGRY to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about SGRY?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Surgery Partners Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Surgery Partners Inc

Current Assets 1.1B
Cash & Short-Term Investments 229.3m
Receivables 570.6m
Other Current Assets 274.7m
Non-Current Assets 6.9B
Long-Term Investments 218.6m
PP&E 1.4B
Intangibles 5.2B
Other Non-Current Assets 55.8m
Efficiency

Free Cash Flow Analysis
Surgery Partners Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Surgery Partners Inc

Revenue
3.2B USD
Cost of Revenue
-2.3B USD
Gross Profit
841.1m USD
Operating Expenses
-367.6m USD
Operating Income
473.5m USD
Other Expenses
-666.9m USD
Net Income
-193.4m USD
Fundamental Scores

SGRY Profitability Score
Profitability Due Diligence

Surgery Partners Inc's profitability score is 44/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Positive Free Cash Flow
Positive Revenue Growth Forecast
44/100
Profitability
Score

Surgery Partners Inc's profitability score is 44/100. The higher the profitability score, the more profitable the company is.

SGRY Solvency Score
Solvency Due Diligence

Surgery Partners Inc's solvency score is 28/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Average D/E
Positive Net Debt
28/100
Solvency
Score

Surgery Partners Inc's solvency score is 28/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SGRY Price Targets Summary
Surgery Partners Inc

Wall Street analysts forecast SGRY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SGRY is 32.66 USD with a low forecast of 24.24 USD and a high forecast of 37.8 USD.

Lowest
Price Target
24.24 USD
4% Upside
Average
Price Target
32.66 USD
40% Upside
Highest
Price Target
37.8 USD
62% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Surgery Partners Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for SGRY is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

SGRY Insider Trading
Buy and sell transactions by insiders

SGRY News

Other Videos
What is the Intrinsic Value of one SGRY stock?

The intrinsic value of one SGRY stock under the Base Case scenario is 40.9 USD.

Is SGRY stock undervalued or overvalued?

Compared to the current market price of 23.32 USD, Surgery Partners Inc is Undervalued by 43%.

Back to Top